Director, Formulation Development
CurrentDirected R&D activities in developing analytical methods and formulating both inhalation and oral drug candidates. Developed and managed a Quality program in-house to support Phase 1 GMP activites, which included method qualifications, QC testing, OOS investigations, and training.